Yes, clinical trials conducted abroad can be acceptable for Korea medical device registration, provided they meet the standards set by the Ministry of Food and Drug Safety (MFDS). The trials must adhere to Good Clinical Practice (GCP) guidelines and demonstrate relevance to the Korean population, ensuring safety and efficacy.